Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 434 entries
View as:

Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01016379 Org: User:
Start: 11/30/09 End: 05/31/16 Due: 05/31/17

Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00107471 Org: User:
Start: 10/31/05 End: - Due: -

Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00070174 Org: User:
Start: 12/31/03 End: 12/31/13 Due: 12/31/14

Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01374672 Org: User:
Start: 07/31/11 End: 09/30/11 Due: 09/30/12

Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003735 Org: User:
Start: 12/31/98 End: 09/30/06 Due: 09/30/07

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003203 Org: User:
Start: 03/31/98 End: 03/31/12 Due: 03/31/13

Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01824693 Org: User:
Start: 06/24/13 End: 12/31/17 Due: 12/31/18

Studying Biomarkers in Samples From Younger Patients With Wilms Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01576198 Org: User:
Start: 04/30/12 End: - Due: -

Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study

Phase: N/A Priority: Normal
NCT ID: NCT04089358 Org: User:
Start: 12/07/20 End: 12/31/25 Due: 12/31/26

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT06858501 Org: User:
Start: 09/22/25 End: 12/20/28 Due: 12/20/29

Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201

Phase: N/A Priority: Normal
NCT ID: NCT00028509 Org: User:
Start: 07/31/02 End: - Due: -

MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02444884 Org: User:
Start: 09/30/08 End: 12/31/11 Due: 12/31/12

Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression

Phase: N/A Priority: Normal
NCT ID: NCT01433224 Org: User:
Start: 10/31/11 End: 05/31/16 Due: 05/31/17

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00352534 Org: User:
Start: 11/06/06 End: 09/30/25 Due: 09/30/26

Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00138216 Org: User:
Start: 10/31/05 End: 01/31/11 Due: 01/31/12

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00379340 Org: User:
Start: 02/26/07 End: 09/30/25 Due: 09/30/26

A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat

Phase: N/A Priority: Normal
NCT ID: NCT05320380 Org: User:
Start: 08/01/23 End: 09/01/23 Due: 09/01/24

Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00005945 Org: User:
Start: 06/30/00 End: 06/30/08 Due: 06/30/09

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002941 Org: User:
Start: 04/30/98 End: 03/31/07 Due: 03/31/08

Biomarkers in Patients With Advanced Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01668095 Org: User:
Start: 08/31/12 End: - Due: -

Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00006095 Org: User:
Start: 07/31/00 End: 09/30/05 Due: 09/30/06

Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial

Phase: N/A Priority: Normal
NCT ID: NCT01629745 Org: User:
Start: 06/30/12 End: 05/31/16 Due: 05/31/17

Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01245231 Org: User:
Start: 05/31/10 End: - Due: -

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01503515 Org: User:
Start: 03/21/13 End: 09/30/21 Due: 09/30/22

Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission

Phase: N/A Priority: Normal
NCT ID: NCT00268528 Org: User:
Start: 05/30/05 End: 06/30/20 Due: 06/30/21